Error: Could not add to watchlist. X

Isis Pharmaceuticals Inc

+ Watchlist
ISI:GR
Frankfurt
51.22
EUR
0.38
0.74%
As of 14:19:02 ET on 07/01/2015.
Open
51.63
Day Range
51.09 - 52.49
Volume
115
Previous Close
51.60
52Wk Range
19.95 - 72.68
1 Yr Return
98.90%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (b EUR)
6.132
Shares Outstanding (m)
119.713
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Isis Pharmaceuticals, Inc. discovers and develops novel human therapeutic compounds. The company currently has various compounds in clinical trials for a variety of diseases such as Crohn's disease, psoriasis, asthma, and cancer. Isis' broad medical chemistry and biology research programs support efforts in both antisense and small molecule drug delivery.
ADDRESS
1896 Rutherford Road
Carlsbad, CA 92008-7326
United States
PHONE
1-760-931-9200
  • Stanley T Crooke "Stan"
    Chairman/President/CEO/Founder
  • B Lynne Parshall
    COO/Secretary
  • Sarah Boyce
    Chief Business Officer
  • Elizabeth L Hougen
    Senior VP:Finance/CFO
  • Patrick R O'Neil
    Senior VP:Legal/Gen Counsel
Show More